DSCR9 and cancer: Forced overexpression of DSCR9 in pancreatic cancer cells inhibited the proliferation and invasive ability of cancer cells while enhancing gemcitabine-induced apoptosis, suggesting that DSCR9 has a tumor-suppressive effect on pancreatic cancer.